Latest Schedule 13D activist filings

Utz Brands, Inc. announces a definitive agreement to be acquired by Intersnack Group GmbH & Co. KG for $14.25 per share in cash, with a total transaction value implied by the merger agreement.

An amendment to Schedule 13D details the beneficial ownership of EchoStar Corporation Class A and Class B common stock by Charles W. Ergen, Cantey M. Ergen, and related entities as of July 20, 2026.

Oramed Pharmaceuticals Inc. reports changes in beneficial ownership of Nano Dimension Ltd. ordinary shares, including option and put option transactions.

Oramed Pharmaceuticals Inc. reports changes in beneficial ownership of Nano Dimension Ltd. ordinary shares, including option and put option transactions.

BW Group Limited has disclosed the sale of a significant portion of its stake in Navigator Holdings Ltd., reducing its beneficial ownership to 8.83% through open market transactions.

Edward Pershing amends Schedule 13D, reporting 11.61% beneficial ownership of Provectus Biopharmaceuticals common stock, including convertible notes and options.

Juvenescence Limited and its subsidiaries now beneficially own approximately 27.3% of Serina Therapeutics, Inc. following a recent private placement.

Sky Frontier Foundation updates its Schedule 13D filing to reflect a change in beneficial ownership percentage due to an increase in Stablecoin Development Corp's outstanding shares.

Penske Corporation and Roger S. Penske, along with Mitsui & Co., have submitted a non-binding proposal to acquire all outstanding shares of Penske Automotive Group not already owned by the investor group for $210.00 per share.

Mitsui & Co. and its affiliate have submitted a non-binding proposal to acquire all outstanding shares of Penske Automotive Group not already owned for $210 per share in cash.

Jonathan M. Rothberg and associated entities have filed an amendment to their Schedule 13D, detailing recent stock transactions and beneficial ownership of Butterfly Network, Inc.

An amendment to a Schedule 13D filing reveals updated beneficial ownership details for W. R. Berkley Corporation, with reporting persons collectively holding 25.67% of outstanding shares.

Jakhongir Abidovich Artikkhodjaev acquired 1,000,000 shares of StageWise Strategies Corp. common stock, increasing his beneficial ownership to 79.3%.

Research Alliance Holdings IV LLC and Matthew Hammond have jointly filed a Schedule 13D, reporting beneficial ownership of 17.0% of Research Alliance Corporation IV's Class A Ordinary Shares following the company's IPO and private placement.

Daniel Reis-Faria, CEO of ZeroStack Corp., has increased his beneficial ownership to 37.5% through the exercise of pre-funded warrants and a significant stock option grant.

Dany Vaiman, CFO of ZeroStack Corp., reports beneficial ownership of 513,249 shares (2.9%) and details a shareholder-approved stock option grant tied to VWAP performance.

Michael Heinrich and Zero Gravity Labs Inc. report beneficial ownership of 30.2% and 26.4% of ZeroStack Corp. common shares respectively, totaling over 56% combined.

RA Capital Management, L.P. and its affiliates have amended their Schedule 13D filing to report changes in beneficial ownership of VOR BIOPHARMA INC. common stock.

KORE Group Holdings, Inc. announces the consummation of its merger, with shares to be delisted from the NYSE and converted to cash.

Tempus AI has entered into a Merger Agreement to acquire all outstanding common stock of Personalis, Inc., with consideration to be paid in Tempus Class A Common Stock or a mix of cash and stock.

Tempus AI has entered into a Merger Agreement to acquire all outstanding common stock of Personalis, Inc., with consideration to be paid in Tempus Class A Common Stock or a mix of cash and stock.

KORE Group Holdings, Inc. has completed its merger, with common stock shareholders receiving $9.25 per share in cash, and the stock has been delisted from the NYSE.

Goldenwise Capital Group, a significant Phunware shareholder, has publicly called for a complete overhaul of the company's corporate governance, citing poor performance and lack of accountability.

BNDES and BNDESPAR have reduced their beneficial ownership of Petrobras preferred shares to 15.90% following open market sales.

OrbiMed Advisors LLC and affiliated entities have filed an amendment to their Schedule 13D, reporting a decrease in their beneficial ownership of Q32 Bio Inc. common stock due to an increase in outstanding shares.

Nano Dimension and Murchinson Ltd. have reached a settlement agreement, leading to the cancellation of the July 31, 2026 Extraordinary General Meeting and a reconstitution of the Company's Board of Directors.

Peter M. Hecht amends Schedule 13D, reporting a beneficial ownership of 910,240 shares of Cyclerion Therapeutics' common stock, representing 19.4% of the class.

MD Ehsan Khan has filed an amendment to report the sale of all previously held shares in Boxlight Corp, indicating no further plans with the issuer.

Atlas Capital Resources entities have increased their beneficial ownership in Vulcan Infrastructure and Power Inc. to 23.1% through a private placement and new investor rights.

Fairmount Funds Management LLC and its affiliates have increased their beneficial ownership in Crescent Biopharma, Inc. to 16.52% through recent share and warrant purchases.